Top compounds associated with response to ACBD7


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.13 1e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA methylstat CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV